PROM1 and colonic neoplasm: Next, we treated the GPR56 positive colon cancer cells for two days with 1 nmol/ml of progastrin, FACS analyzed the CD133 positive cell population, and found significantly increased CD133 expression in GPR56 expressing cells (Figure 3D, 3E).